GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Farmax India Ltd (LUX:FARMX) » Definitions » Piotroski F-Score

Farmax India (LUX:FARMX) Piotroski F-Score : 0 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Farmax India Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Farmax India has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Farmax India's Piotroski F-Score or its related term are showing as below:

During the past 9 years, the highest Piotroski F-Score of Farmax India was 6. The lowest was 0. And the median was 3.


Farmax India Piotroski F-Score Historical Data

The historical data trend for Farmax India's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmax India Piotroski F-Score Chart

Farmax India Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 2.00 6.00 1.00 3.00 -

Farmax India Quarterly Data
Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Jun15 Dec15 Mar16 Jun16 Dec16 Mar17 Dec17
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 - - - -

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar17) TTM:Last Year (Mar16) TTM:
Net Income was $-0.42 Mil.
Cash Flow from Operations was $0.00 Mil.
Revenue was $0.67 Mil.
Gross Profit was $-0.12 Mil.
Average Total Assets from the begining of this year (Mar16)
to the end of this year (Mar17) was (5.061 + 4.662) / 2 = $4.8615 Mil.
Total Assets at the begining of this year (Mar16) was $5.06 Mil.
Long-Term Debt & Capital Lease Obligation was $0.11 Mil.
Total Current Assets was $1.26 Mil.
Total Current Liabilities was $6.33 Mil.
Net Income was $-1.47 Mil.

Revenue was $2.45 Mil.
Gross Profit was $-0.94 Mil.
Average Total Assets from the begining of last year (Mar15)
to the end of last year (Mar16) was (7.162 + 5.061) / 2 = $6.1115 Mil.
Total Assets at the begining of last year (Mar15) was $7.16 Mil.
Long-Term Debt & Capital Lease Obligation was $0.11 Mil.
Total Current Assets was $1.51 Mil.
Total Current Liabilities was $6.32 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Farmax India's current Net Income (TTM) was -0.42. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Farmax India's current Cash Flow from Operations (TTM) was 0.00. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar16)
=-0.419/5.061
=-0.08278996

ROA (Last Year)=Net Income/Total Assets (Mar15)
=-1.469/7.162
=-0.2051103

Farmax India's return on assets of this year was -0.08278996. Farmax India's return on assets of last year was -0.2051103. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Farmax India's current Net Income (TTM) was -0.42. Farmax India's current Cash Flow from Operations (TTM) was 0.00. ==> 0.00 > -0.42 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar16 to Mar17
=0.112/4.8615
=0.02303816

Gearing (Last Year: Mar16)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar15 to Mar16
=0.11/6.1115
=0.01799885

Farmax India's gearing of this year was 0.02303816. Farmax India's gearing of last year was 0.01799885. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar17)=Total Current Assets/Total Current Liabilities
=1.256/6.333
=0.19832623

Current Ratio (Last Year: Mar16)=Total Current Assets/Total Current Liabilities
=1.514/6.324
=0.23940544

Farmax India's current ratio of this year was 0.19832623. Farmax India's current ratio of last year was 0.23940544. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Farmax India's number of shares in issue this year was 0. Farmax India's number of shares in issue last year was 0. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-0.121/0.666
=-0.18168168

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-0.941/2.453
=-0.3836119

Farmax India's gross margin of this year was -0.18168168. Farmax India's gross margin of last year was -0.3836119. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar16)
=0.666/5.061
=0.13159455

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar15)
=2.453/7.162
=0.34250209

Farmax India's asset turnover of this year was 0.13159455. Farmax India's asset turnover of last year was 0.34250209. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Farmax India has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Farmax India  (LUX:FARMX) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Farmax India Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Farmax India's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmax India (LUX:FARMX) Business Description

Traded in Other Exchanges
N/A
Address
Survey Number 658, Bowrampet Village, Qutubullapur Mandal, Ranga Reddy District, Hyderabad, Telengana, IND, 500043
Farmax India Ltd is mainly engaged in the manufacturing and marketing of fast moving consumer goods. The company offers food products; personal care products, soaps and detergent powders under the brand name Today, D' Lite, Deevena, Farmax, Monsoon, and Cas brands.

Farmax India (LUX:FARMX) Headlines

No Headlines